These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6446742)

  • 1. Physiological versus pathological myocardial hypertrophy.
    Wikman-Coffelt J; Laks MM; Riemenschneider T; Mason DT
    Adv Myocardiol; 1980; 1():469-76. PubMed ID: 6446742
    [No Abstract]   [Full Text] [Related]  

  • 2. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development.
    Wikman-Coffelt J; Parmley WW; Mason DT
    Circ Res; 1979 Dec; 45(6):697-707. PubMed ID: 159142
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery of myosin ATPase after relief of pressure-overload hypertrophy and failure.
    Carey RA; Bove AA; Coulson RL; Spann JF
    Am J Physiol; 1978 Jun; 234(6):H711-7. PubMed ID: 149505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical problems in cardiac hypertrophy and chronic insufficiency].
    Swynghedauw B
    Nouv Presse Med; 1979 Oct; 8(38):3021-4. PubMed ID: 160541
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of physiologic versus pathologic ventricular hypertrophy process: enhanced or depressed myosin ATPase activity and contractility governed by type, degree and duration of inciting stress.
    Wikman-Coffelt J; Laks MM; Riemenschneider TH; Mason DT
    Basic Res Cardiol; 1980; 75(1):149-56. PubMed ID: 6446284
    [No Abstract]   [Full Text] [Related]  

  • 6. The excitation-contraction coupling system of the myocardium in canine hemorrhagic shock.
    Warner M; Smith JM; Eaton R; Robbins A; Hess ML
    Circ Shock; 1981; 8(5):563-72. PubMed ID: 6456852
    [No Abstract]   [Full Text] [Related]  

  • 7. [Deterioration and improvement of cardiac hypertrophy].
    Kimata S; Kawana M; Taira A; Ishizuka H; Hirosawa K; Yazaki Y; Tsuchimochi H; Koyanagi H; Hashimoto A
    Kokyu To Junkan; 1987 Jul; 35(7):723-33. PubMed ID: 2958917
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and subcellular basis of myocardial hypertrophy. Introduction .
    Alpert NR
    Fed Proc; 1986 Oct; 45(11):2561-2. PubMed ID: 2944765
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased contractility after myocardial hypertrophy: cardiac failure or successful adaptation?
    Swynghedauw B; Schwartz K; Apstein CS
    Am J Cardiol; 1984 Aug; 54(3):437-40. PubMed ID: 6235737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Maximum load capacity in pressure-induced cardiac hypertrophy].
    Bischoff KO; Stephan K; Gülker H; Meesmann W
    Verh Dtsch Ges Inn Med; 1975; 81():328-30. PubMed ID: 132800
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonuniformity: an important physiological modulator of the contractile performance of the normal heart.
    Brutsaert DL
    Verh K Acad Geneeskd Belg; 1985; 47(4):257-86. PubMed ID: 2934903
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural and functional properties of myosin associated with the compensatory cardiac hypertrophy in the rabbit.
    Shiverick CT; Hamrell BB; Alpert NR
    J Mol Cell Cardiol; 1976 Nov; 8(11):837-51. PubMed ID: 137321
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertrophy, a physiological adaptation of the heart to a disease].
    Swynghedauw B; Schwartz K
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1249-51. PubMed ID: 6318679
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between cardiac muscle myosin ATPase activity and velocity of muscle shortening.
    Carey RA; Bove AA; Coulson RL; Spann JF
    Biochem Med; 1979 Jun; 21(3):235-45. PubMed ID: 159043
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of chronic infusion of norepinephrine on cardiac structure, function, and biochemistry: physiologic versus pathologic hypertrophy.
    Laks MM
    Clin Cardiol; 1989 Dec; 12(12 Suppl 4):IV50-7. PubMed ID: 2533529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibrillogenesis and reversible disassembly of myofibrills as adaptive reactions of cardiac muscle cells.
    Borisov AB
    Acta Physiol Scand Suppl; 1991; 599():71-80. PubMed ID: 1830999
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.
    Shiojima I; Walsh K
    Genes Dev; 2006 Dec; 20(24):3347-65. PubMed ID: 17182864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of myocardial hypertrophy on the dynamics of restoring diastolic contractile capacity].
    Kapel'ko VI
    Biull Eksp Biol Med; 1974 Oct; 78(10):15-8. PubMed ID: 4282266
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: The myocardial efficiency of the hypertonic heart--bases for evaluations and typical misinterpretations].
    Jacob R; Kämmereit A; Kissling G; Medugorac I
    Z Kardiol; 1975; Suppl 2():78. PubMed ID: 128243
    [No Abstract]   [Full Text] [Related]  

  • 20. Heat, mechanics, and myosin ATPase in normal and hypertrophied heart muscle.
    Alpert NR; Mulieri LA
    Fed Proc; 1982 Feb; 41(2):192-8. PubMed ID: 6460650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.